Cardiology MCQ PCSK9 inhibitor – Cardiology MCQ Johnson Francis | July 31, 2015 The PCSK9 inhibitor which was recently approved by FDA: a) Evolocumab b) Alirocumab c) Infliximab d) Abciximab Read More
General Cardiology Familial hypercholesterolemia Johnson Francis | July 16, 2014 Familial hypercholesterolemia Familial hypercholesterolemia is an autosomal dominant disorder and should be suspected when the total cholesterol levels are above 300 mg/dL in adults and above 250 mg/dL Read More